Top biopharmaceutical companies in cardiometabolic revenue 2020

Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars)

Top biopharmaceutical companies in cardiometabolic care worldwide 2020

Last update:

Nov 8, 2021

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2020 to 31/12/2020

In 2020, the highest total revenue made by a biopharmaceutical companies specialized in cardiometabolic care worldwide was around 28 billion U.S. dollars by Eli Lilly. This statistic illustrates the total revenue of leading biopharmaceutical companies in cardiometabolic worldwide.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars)

Get in touch with us for additional information

��ƽ��